Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MDB Capital Holdings, LLC - Class A common (NQ:MDBH)

4.220 -0.090 (-2.09%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MDB Capital Holdings, LLC - Class A common

< Previous 1 2 Next >
MDB Capital Holdings Provides First Quarter 2025 Update
Management to Host Conference Call Today at 4:30 p.m. ET 
From MDB Capital Holdings, LLC
Via GlobeNewswire
New PatentVest Pulse Report Reveals IP Gaps in Billion-Dollar Humanoid Robotics Startups
Despite rising valuations, most humanoid robotics startups remain underprotected—leaving long-term value at risk 
From PatentVest, Inc.
Via GlobeNewswire
MDB Capital Holdings to Host First Quarter 2025 Results Conference Call on Wednesday May 21, 2025, at 4:30 p.m. Eastern Time
From MDB Capital Holdings, LLC
Via GlobeNewswire
MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time
From MDB Capital Holdings, LLC
Via GlobeNewswire
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
Designed for investors, board members, and CEOs, the latest PatentVest Pulse offers a strategic view of who’s winning—and why—in the emerging BCI market 
From PatentVest, Inc.
Via GlobeNewswire
MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
Management to Host Conference Call Today at 4:30 p.m. ET 
From MDB Capital Holdings, LLC
Via GlobeNewswire
New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race
•China accounts for 77% of all AI data center patent filings globally, with five of the top patent holders hailing from China - underlining its dominant position in next-generation AI infrastructure 
From PatentVest, Inc.
Via GlobeNewswire
Earnings Scheduled For March 31, 2025
Via Benzinga
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
From eXoZymes Inc.
Via GlobeNewswire
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
From eXoZymes Inc.
Via GlobeNewswire
Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025 
From Invizyne Technologies, Inc.
Via GlobeNewswire
Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change
From PatentVest, Inc.
Via GlobeNewswire
MDB Capital Holdings Provides Third Quarter 2024 Update
Management to Host Conference Call Today at 4:30 p.m. ET 
From MDB Capital Holdings, LLC
Via GlobeNewswire
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities
Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce development 
From Invizyne Technologies, Inc.
Via GlobeNewswire
MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time
From MDB Capital Holdings, LLC
Via GlobeNewswire
Invizyne Technologies Announces Closing of Initial Public Offering
From Invizyne Technologies, Inc.
Via GlobeNewswire
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology 
From Invizyne Technologies, Inc.
Via GlobeNewswire
Invizyne Technologies Begins Trading on NASDAQ
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC" 
From Invizyne Technologies, Inc.
Via GlobeNewswire
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC" 
From Invizyne Technologies, Inc.
Via GlobeNewswire
Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering
Shares to Begin Trading on NASDAQ on November 12, 2024, Under the Ticker Symbol “IZTC” 
From Invizyne Technologies, Inc.
Via GlobeNewswire
MDB Capital Teams with TCA Venture Group to Bring New Insights and Public Venture Opportunities to Angel Investors
From MDB Capital Holdings, LLC
Via GlobeNewswire
MDBH Stock Earnings: MDB Capital Holdings Reported Results for Q2 2024
MDB Capital Holdings just reported results for the second quarter of 2024. 
Via InvestorPlace
MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies
From MDB Capital Holdings, LLC
Via GlobeNewswire
Recently Published Whitepaper from PatentVest Delves into Transformative Innovations in MASH Diagnostics
From PatentVest, Inc.
Via GlobeNewswire
MDB Capital Expands Board, Appoints Daniel Torpey as New Director
From MDB Capital Holdings, LLC
Via GlobeNewswire
New PatentVest Pulse Report Reveals Transformative Trends in Portable ECG Monitoring
From PatentVest, Inc.
Via GlobeNewswire
MDB Capital Holdings Unveils Unified Corporate Branding
From MDB Capital Holdings, LLC
Via GlobeNewswire
MDBH Stock Earnings: MDB Capital Holdings Reported Results for Q1 2024
MDB Capital Holdings just reported results for the first quarter of 2024. 
Via InvestorPlace
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
From Invizyne Technologies, Inc.
Via GlobeNewswire
MDB Capital Holdings Year-End Update
Management to Host Zoom Webinar Today at 4:30 p.m. ET 
From MDB Capital Holdings, LLC
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.